HUT34887A - Process for producing composition containing purified detoxicated endotoxin - Google Patents

Process for producing composition containing purified detoxicated endotoxin

Info

Publication number
HUT34887A
HUT34887A HU843169A HU316984A HUT34887A HU T34887 A HUT34887 A HU T34887A HU 843169 A HU843169 A HU 843169A HU 316984 A HU316984 A HU 316984A HU T34887 A HUT34887 A HU T34887A
Authority
HU
Hungary
Prior art keywords
detoxicated
endotoxin
composition containing
containing purified
producing composition
Prior art date
Application number
HU843169A
Other languages
Hungarian (hu)
Other versions
HU191713B (en
Inventor
Edgar E Ribi
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of HUT34887A publication Critical patent/HUT34887A/en
Publication of HU191713B publication Critical patent/HU191713B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55544Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A composition which is capable of producing an effective adjuvant response or stimulating the immune response of a warm blooded animal which comprises an effective amount of a refined detoxified endotoxin material, in combination with a pharmaceutically acceptable carrier.
HU843169A 1983-08-26 1984-08-23 Process for producing composition containing purified detoxicated endotoxin HU191713B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52696783A 1983-08-26 1983-08-26

Publications (2)

Publication Number Publication Date
HUT34887A true HUT34887A (en) 1985-05-28
HU191713B HU191713B (en) 1987-03-30

Family

ID=24099553

Family Applications (1)

Application Number Title Priority Date Filing Date
HU843169A HU191713B (en) 1983-08-26 1984-08-23 Process for producing composition containing purified detoxicated endotoxin

Country Status (22)

Country Link
JP (1) JPS6072825A (en)
KR (1) KR880002223B1 (en)
AT (1) AT389228B (en)
AU (1) AU554039B2 (en)
BE (1) BE900377A (en)
CA (1) CA1225592A (en)
CH (1) CH660125A5 (en)
DE (2) DE3448164C2 (en)
DK (1) DK389384A (en)
ES (1) ES8606883A1 (en)
FI (1) FI843204A (en)
FR (1) FR2550945B1 (en)
GB (1) GB2147806B (en)
HU (1) HU191713B (en)
IL (1) IL72675A (en)
IN (1) IN157910B (en)
IT (1) IT1177974B (en)
NL (1) NL192326C (en)
NO (1) NO843243L (en)
NZ (1) NZ209233A (en)
SE (1) SE8404090L (en)
ZA (1) ZA846309B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629722A (en) * 1984-07-12 1986-12-16 Ribi Immunochem Research, Inc. Method of inhibiting the onset of acute radiation syndrome
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
DE10115310A1 (en) * 2001-03-28 2002-10-10 Nodar A Daniela Bacteriophage preparation
KR100868443B1 (en) * 2002-05-27 2008-11-11 주식회사 포스코 An apparatus for bending a strip packing sheet

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2160326B1 (en) * 1971-11-19 1975-02-07 Anvar
BE793260A (en) * 1971-12-24 1973-06-22 Pasteur Institut IMMUNOSTIMULANT AGENT, MEDICINES CONTAINING IT AND METHOD FOR MANUFACTURING SUCH IMMUNOSTIMULANT AGENT
DE2527636A1 (en) * 1974-06-20 1976-01-08 Anvar METHOD FOR PRODUCING MYCOBACTERIAL FRACTIONS
FR2393065A1 (en) * 1977-05-31 1978-12-29 Merieux Inst PROCESS FOR SEPARATION OF LIPIDS FROM BACTERIAL ENDOTOXINS AND IN PARTICULAR FROM BORDETELLA PERTUSSIS ENDOTOXIN
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product

Also Published As

Publication number Publication date
FR2550945B1 (en) 1988-09-16
IL72675A (en) 1988-04-29
DE3431058A1 (en) 1985-03-07
DK389384D0 (en) 1984-08-13
NL8402515A (en) 1985-03-18
DK389384A (en) 1985-02-27
BE900377A (en) 1985-02-18
KR850001696A (en) 1985-04-01
GB2147806A (en) 1985-05-22
NO843243L (en) 1985-02-27
KR880002223B1 (en) 1988-10-20
ATA273384A (en) 1989-04-15
IL72675A0 (en) 1984-11-30
AU3221584A (en) 1985-02-28
ZA846309B (en) 1985-03-27
IT8448757A0 (en) 1984-08-24
FI843204A0 (en) 1984-08-14
CH660125A5 (en) 1987-03-31
DE3431058C2 (en) 1987-06-11
NL192326B (en) 1997-02-03
IT8448757A1 (en) 1986-02-24
DE3448164C2 (en) 1987-06-25
JPH0556326B2 (en) 1993-08-19
ES535124A0 (en) 1986-05-01
IT1177974B (en) 1987-09-03
FI843204A (en) 1985-02-27
AU554039B2 (en) 1986-08-07
SE8404090D0 (en) 1984-08-14
AT389228B (en) 1989-11-10
IN157910B (en) 1986-07-19
JPS6072825A (en) 1985-04-24
GB8420612D0 (en) 1984-09-19
GB2147806B (en) 1986-10-22
HU191713B (en) 1987-03-30
FR2550945A1 (en) 1985-03-01
NL192326C (en) 1997-06-04
NZ209233A (en) 1987-11-27
SE8404090L (en) 1985-02-27
CA1225592A (en) 1987-08-18
ES8606883A1 (en) 1986-05-01

Similar Documents

Publication Publication Date Title
GB2210557B (en) Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant.
IL73034A (en) Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism
AU566011B2 (en) Leather treatment composition
HUT35287A (en) Process for preparing immune interferon
EP0294028A3 (en) Fluoxetine useful for the treatment of diabetes
GB2211845B (en) Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles
EP0253313A3 (en) Process for heat treating chemically unmodified gamma-globulin
HUT34887A (en) Process for producing composition containing purified detoxicated endotoxin
GR871606B (en) 7- deazaguanines as immun omodulators
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
EP0266633A3 (en) Process for the preparation of organopolysiloxanes containing sih-bonds
HUT43107A (en) Process for producing vaccine against melanome
EP0254068A3 (en) Novel therapeutic agent for gastritis
PL238609A2 (en) Process for preparing novel pyrimidine/1,3/oxazin-2,4-diones
ZA838815B (en) Process for the preparation of n,n'-diformylhydrazine
CA49742S (en) Treatment chair
CA49712S (en) Table ornament
CA50525S (en) Table ornament
ZA827535B (en) A composition for progestational adjuvant therapy
SU1486325A1 (en) Method of preparing parts to the treatment
BG33354A1 (en) Method for obtaining of 3- substttuated- 1, 2, 4- oxadiazol